WO2009013405A8 - Controle de la fertilite d'un etre humain de sexe masculin via spata16 - Google Patents

Controle de la fertilite d'un etre humain de sexe masculin via spata16 Download PDF

Info

Publication number
WO2009013405A8
WO2009013405A8 PCT/FR2008/000858 FR2008000858W WO2009013405A8 WO 2009013405 A8 WO2009013405 A8 WO 2009013405A8 FR 2008000858 W FR2008000858 W FR 2008000858W WO 2009013405 A8 WO2009013405 A8 WO 2009013405A8
Authority
WO
WIPO (PCT)
Prior art keywords
spata
human male
male fertility
fertility control
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2008/000858
Other languages
English (en)
Other versions
WO2009013405A3 (fr
WO2009013405A2 (fr
Inventor
Stephane Viville
Jan A M Kremer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Original Assignee
Centre National de la Recherche Scientifique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique filed Critical Centre National de la Recherche Scientifique
Publication of WO2009013405A2 publication Critical patent/WO2009013405A2/fr
Publication of WO2009013405A8 publication Critical patent/WO2009013405A8/fr
Publication of WO2009013405A3 publication Critical patent/WO2009013405A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente demande est relative au contrôle de la fertilité de l'être humain de sexe masculin. Les inventeurs démontrent que la protéine SPATA16 est nécessaire à la formation de l'acrosome des spermatozoïdes humaines et à ce titre, proposent des moyens pour la contraception de l'être humain de sexe masculin, et des moyens pour le diagnostic et Ie pronostic d'une tératozoospermie, plus particulièrement d'une globozoospermie.
PCT/FR2008/000858 2007-06-29 2008-06-19 Controle de la fertilite d'un etre humain de sexe masculin via spata16 Ceased WO2009013405A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0704719 2007-06-29
FR0704719A FR2918075A1 (fr) 2007-06-29 2007-06-29 Controle de la fertilite d'un etre humain de sexe masculin via spata16

Publications (3)

Publication Number Publication Date
WO2009013405A2 WO2009013405A2 (fr) 2009-01-29
WO2009013405A8 true WO2009013405A8 (fr) 2009-03-19
WO2009013405A3 WO2009013405A3 (fr) 2009-05-14

Family

ID=38968877

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/000858 Ceased WO2009013405A2 (fr) 2007-06-29 2008-06-19 Controle de la fertilite d'un etre humain de sexe masculin via spata16

Country Status (2)

Country Link
FR (1) FR2918075A1 (fr)
WO (1) WO2009013405A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101772717B1 (ko) 2009-11-10 2017-08-29 인터디지탈 패튼 홀딩스, 인크 인터넷 프로토콜 멀티미디어 서브시스템에서의 공동 세션 제어 이동 및 장치 간 이동
FR2952373B1 (fr) 2009-11-12 2013-05-17 Univ Grenoble 1 Controle de la fertilite humaine via dpy19l2
CN105119904B (zh) 2010-03-04 2018-10-26 交互数字专利控股公司 网际协议多媒体子系统协同会话中的识别和传递的方法
AU2011227085B2 (en) 2010-03-18 2016-06-30 Interdigital Patent Holdings, Inc Authorizing inter user element session transfer
CN105085675A (zh) * 2014-05-14 2015-11-25 深圳市第二人民医院 鼠spata16基因多克隆抗体及其制备方法
EP4153183A4 (fr) * 2020-06-01 2024-08-07 Corona Feed Additives, L.L.C. Composition, système et méthode de contraception de porc

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0210436A (pt) * 2001-06-19 2004-08-17 Population Council Inc Contraceptivo masculino, métodos de contracepção, e de produção de um contraceptivo masculino, fragmento de peptìdeo do segundo domìnio extracelular de uma ocludina de mamìfero, molécula de dna, vetor, e, hospedeiro não-humano
CN1869222A (zh) * 2005-05-24 2006-11-29 中国医学科学院基础医学研究所 大鼠睾丸高表达基因rDJL参与精子顶体形成

Also Published As

Publication number Publication date
WO2009013405A3 (fr) 2009-05-14
WO2009013405A2 (fr) 2009-01-29
FR2918075A1 (fr) 2009-01-02

Similar Documents

Publication Publication Date Title
WO2009021754A3 (fr) Anticorps monospécifiques et multispécifiques, et procédés d'utilisation
WO2007124317A3 (fr) Système d'ancrage pour appareils prothétiques orthétiques
WO2009013405A3 (fr) Controle de la fertilite d'un etre humain de sexe masculin via spata16
MX2009007254A (es) Composiciones de tableta en tableta.
MX2009004616A (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente.
EA200801758A1 (ru) Лекарственные формы, устойчивые к самовольному изменению
NZ595790A (en) Method for on-demand contraception
WO2008073446A3 (fr) Procédés et systèmes relatifs à la transmission d'informations associées à des nutraceutiques
WO2007100617A3 (fr) Composés à base d'imidazole, compositions les comprenant et leurs méthodes d'utilisation
WO2008025015A8 (fr) Échafaudages d'épitope et de transplant et leurs utilsation
WO2007093627A3 (fr) Composition biocide
WO2008066784A3 (fr) Expression de foxp3 par des cellules cancéreuses
WO2007128802A3 (fr) Utilisation de flibansérine pour le traitement des troubles de la libido post-ménopausiques
WO2008149353A3 (fr) Composés activant la télomérase et leurs procédés d'utilisation
WO2008058056A3 (fr) Dispositifs de vasectomie et trousse et procédé d'utilisation
WO2005121321A3 (fr) Compositions comprenant des cellules souches germinales femelles et leurs procedes d'utilisation
UA95447C2 (ru) Способ женской контрацепции
MX2007005587A (es) Nueva composicion para facilitar el parto humano.
WO2007144057A3 (fr) Carbone antimicrobien
WO2007083190A8 (fr) Extrait d'helychrisum insoluble dans l'eau, et procédés d'élaboration et d'utilisation correspondants
WO2008030564A3 (fr) Anticorps aglycosylés et procédés de fabrication et d'utilisation de ces anticorps
WO2009073612A3 (fr) Remèdes homéopathiques destinés à être utilisés avant et après des opérations esthétiques injectables et chirurgicales afin de minimiser le gonflement et les ecchymoses
TW200744584A (en) Use of mGluR5 antagonists (ESP. AFQ056) in GI (ESP. GERD)
WO2006116349A3 (fr) Formulation a liberation prolongee et tableaux de dosage d'inhibiteurs de la synthese de leukotriene pour la therapie humaine
WO2008090831A1 (fr) Composition enzymatique et son utilisation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08826552

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08826552

Country of ref document: EP

Kind code of ref document: A2